Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ENN Group is a prominent Chinese conglomerate that has established a significant presence in the healthcare and life sciences sectors through its Deep Health strategy. The company integrates digital technology, traditional Chinese medicine (TCM), and modern biological research to offer a comprehensive health management ecosystem. Its flagship digital platform, LaiKang, utilizes AI and big data to provide personalized wellness solutions and chronic disease monitoring. ENN's life science research focuses on the gut microbiome, metabolic health, and the modernization of TCM therapies. By combining physical wellness centers with advanced diagnostic tools, the company aims to promote longevity and proactive health management. ENN Group continues to invest in biotechnology to bridge the gap between traditional healing practices and evidence-based digital health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ENN Group.